Imvax is a clinical-stage biotechnology company developing personalized, whole tumor-derived immunotherapies. Imvax’s combination therapy uniquely captures the complete antigenic signature of a patient’s own tumor and converts it into a highly stimulatory ‘training program’ for the patient’s immune system. The comprehensive nature of this training is intended to result in both innate and adaptive immune stimulation to optimize long-term anti-tumor effects.
The company’s lead program is in glioblastoma multiforme (GBM), an extremely aggressive form of brain cancer, with additional programs in other types of solid tumors.
Location: United States, Pennsylvania, Philadelphia
Employees: 11-50
Total raised: $135M
Founded date: 2015
Investors 1
| Date | Name | Website |
| - | Reimagined... | reimagined... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 07.09.2023 | - | $23M | - |
| 16.07.2020 | Series C | $112M | - |
Mentions in press and media 12
| Date | Title | Description | Source |
| 16.01.2024 | EBCI Brings Awareness to How Newly Diagnosed Glioblastoma Pa... | End Brain Cancer Initiative IMVAX The End Brain Cancer Initiative (EBCI) Brings Awareness to How N... | einpresswi... |
| 07.09.2023 | Cancer-focused biotech company Imvax raised $23M to advance ... | Cancer-focused biotech company Imvax announced the initial closing of a $23 million fundraising roun... | technical.... |
| 26.01.2021 | Imvax Announces Publication of Phase 1b Clinical Trial of IG... | PHILADELPHIA, Jan. 26, 2021 /PRNewswire/ -- Imvax, Inc., an emerging oncology leader that is revol... | prnewswire... |
| 19.10.2020 | Defying predictions of tumult, Philly companies still raked ... | After concern that the coronavirus pandemic would wipe out all chance of venture capital dollars for... | technical.... |
| 20.07.2020 | These Philly-area Bio and Medtech Companies Raised $116M | Despite the pandemic being very bad for local jobs and a handful of industries, it appears that vent... | citybizlis... |
| 20.07.2020 | These Philly-area Bio and Medtech Companies Raised $116M | Despite the pandemic being very bad for local jobs and a handful of industries, it appears that vent... | archive.ci... |
| 20.07.2020 | Money Moves: These Philly-area bio and medtech companies rai... | Money Moves is a column where we chart the funding raises of tech companies across the region. Have ... | technical.... |
| 16.07.2020 | Imvax raises $112M to advance brain cancer cell therapy | Imvax has raised $112 million to take its autologous tumor cell vaccine into a phase 2 glioblastoma ... | fiercebiot... |
| 16.07.2020 | Imvax raises $112M to advance brain cancer cell therapy W h... | Imvax has raised $112 million to take its autologous tumor cell vaccine into a phase 2 glioblastoma ... | fiercebiot... |
| 16.07.2020 | Imvax Raises $112M In Series C | Imvax, Inc., a clinical-stage biotechnology company whose groundbreaking personalized neo-antigen im... | citybizlis... |
Show more